Reduction in diabetes-induced craniofacial defects by maternal immune stimulation

Birth Defects Research Part B - Developmental and Reproductive Toxicology

Volumn 77, Issue 1, 2006, Pages 1-9

  Hrubec, Terry C ^a,b   Prater, M Renee ^a,b   Toops, Kimberly A ^b   Holladay, Steven D ^b  

^a EDWARD VIA COLLEGE OF OSTEOPATHIC MEDICINE   (United States)

^b VIRGINIA MARYLAND REGIONAL COLLEGE OF VETERINARY MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FREUND ADJUVANT; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; STREPTOZOCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREEDING; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; FETUS; HYPERGLYCEMIA; IMMUNOSTIMULATION; INCIDENCE; MALE; MOUSE; NEURAL TUBE DEFECT; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; CRANIOFACIAL ABNORMALITIES; DIABETES COMPLICATIONS; DIABETES MELLITUS, EXPERIMENTAL; EMBRYO; EMBRYO, MAMMALIAN; FEMALE; MICE; MICE, INBRED ICR; PREGNANCY; STREPTOZOCIN;

ANIMALIA;

EID: 33645901200     PISSN: 15429733     EISSN: None     Source Type: Journal    
DOI: 10.1002/bdrb.20062     Document Type: Article

References (44)

1. Baker L, Piddington R, Goldman A, Egler J, Moehring J. 1990. Myoinositol and prostaglandins reverse the glucose inhibition of neural tube fusion in cultured mouse embryos. Diabetologia 33:593-596.
2. Brault V, Moore R, Kutsch S, Ishibashi M, Rowitch DH, McMahon AP, Sommer L, Boussadia O, Kemler R. 2001. Inactivation of the beta-catenin gene by Wnt1-Cre-mediated deletion results in dramatic brain malformation and failure of craniofacial development. Development 128:1253-1264.
3. Carstens MH. 2004. Neural tube programming and craniofacial cleft formation. I. The neuromeric organization of the head and neck. Eur J Paediatr Neurol 8:181-210.
4. Cederberg J, Picard JJ, Eriksson UJ. 2003. Maternal diabetes in the rat impairs the formation of neural-crest derived cranial nerve ganglia in the offspring. Diabetologia 1245-1251.
5. Chan BW, Chan KS, Koide T, Yeung SM, Leung MB, Copp AJ, Loeken MR, Shiroishi T, Shum AS. 2002. Maternal diabetes increases the risk of caudal regression caused by retinoic acid. Diabetes 51:2811-2816.
6. Clouthier DE, Hosoda K, Richardson JA, Williams SC, Yanagisawa H, Kuwaki T, Kumada M, Hammer RE, Yanagisawa M. 1998. Cranial and cardiac neural crest defects in endothelin-A receptor-deficient mice. Development 125:813-824.
7. Dudas M, Sridurongrit S, Nagy A, Okazaki K, Kaartinen V. 2004. Craniofacial defects in mice lacking BMP type I receptor Alk2 in neural crest cells. Mech Dev 121:173-182.
8. Eriksson UJ, Cederberg J, Wentzel P. 2003. Congenital malformations in offspring of diabetic mothers-animal and human studies. Rev Endocr Metab Disord 4:79-93.
9. Ewart-Toland A, Yankowitz J, Winder A, Imagire R, Cox VA, Aylsworth AS, Golabi M. 2000. Oculoauriculovertebral abnormalities in children of diabetic mothers. Am J Med Genet 90:303-309.
10. Farlie PG, McKeown SJ, Newgreen DF. 2004. The neural crest: basic biology and clinical relationships in the craniofacial and enteric nervous systems. Birth Defects Res C Embryo Today 72:173-189.
11. Fein A, Kostina E, Savion S, Orenstein H, Shepshelovich J, Ornoy A, Torchinsky A, Toder V. 2001. Expression of tumor necrosis factor-alpha in the pregnant uterus of diabetic mice: effect of maternal immunopotentiation. Am J Reprod Immunol 46:161-168.
12. Fein A, Magid N, Savion S, Orenstein H, Shepshelovich J, Ornoy A, Torchinsky A, Toder V. 2002. Diabetes teratogenicity in mice is accompanied with distorted expression of TGF-beta2 in the uterus. Teratog Carcinog Mutagen 22:59-71.
13. Fine EL, Horal M, Chang TI, Fortin G, Loeken MR. 1999. Evidence that elevated glucose causes altered gene expression, apoptosis, and neural tube defects in a mouse model of diabetic pregnancy. Diabetes 48:2454-2462.
14. Gato A, Martinez ML, Tudela C, Alonso I, Moro JA, Formoso MA, Ferguson MW, Martinez-Alvarez C. 2002. TGF-beta(3)-induced chondroitin sulphate proteoglycan mediates palatal shelf adhesion. Dev Biol 250:393-405.
15. Goldman AS, Baker L, Piddington R, Marx B, Herold R, Egler J. 1985. Hyperglycemia-induced teratogenesis is mediated by a functional deficiency of arachidonic acid. Proc Natl Acad Sci USA 82:8227-8231.
16. Goldmuntz E, Emanuel BS. 1997. Genetic disorders of cardiac morphogenesis. The DiGeorge and velocardiofacial syndromes. Circ Res 80:437-443.
17. Grant JH, Maggio-Price L, Reutebuch J, Cunningham ML. 1997. Retinoic acid exposure of the mouse on embryonic day 9 selectively spares derivatives of the frontonasal neural crest. J Craniofac Genet Dev Biol 17:1-8.
18. Holladay SD, Sharova LV, Smit, BJ, Gogal RM Jr, Ward DL, Blaylock BL. 2000. Non-specific stimulation of the maternal immune system: I. Effects on teratogen-induced fetal malformations. Teratology 62:413-419.
19. Hrubec TC, Punareewattana K, Prater MR, Holladay SD. 2005. Teratogen induced birth defects in mice: Role of maternal immune stimulation. Cur Topics Toxicol (in press).
20. Inoue T, Hatayama M, Tohmonda T, Itohara S, Aruga J, Mikoshiba K. 2004. Mouse Zic5 deficiency results in neural tube defects and hypoplasia of cephalic neural crest derivatives. Dev Biol 270:146-162.
21. Juriloff DM, Harris MJ. 2000. Mouse models for neural tube closure defects. Hum Mol Genet 9:993-1000.
22. Kanzler B, Foreman RK, Labosky PA, Mallo M. 2000. BMP signaling is essential for development of skeletogenic and neurogenic cranial neural crest. Development 127:1095-1104.
23. Liao DM, Ng YK, Tay SS, Ling EA, Dheen ST. 2004. Altered gene expression with abnormal patterning of the telencephalon in embryos of diabetic Albino Swiss mice. Diabetologia 47:523-531.
24. Nomura T, Hata S, Kusafuka T. 1990. Suppression of developmental anomalies by maternal macrophages in mice. J Exp Med 172:1325-1330.
25. Phelan SA, Ito M, Loeken MR. 1997. Neural tube defects in embryos of diabetic mice: role of the Pax-3 gene and apoptosis. Diabetes 46:1189-1197.
26. Pinter E, Reece EA, Leranth CZ, Garcia-Segura M, Hobbins JC, Mahoney MJ, Naftolin F. 1986. Arachidonic acid prevents hyperglycemia-associated yolk sac damage and embryopathy. Am J Obstet Gynecol 155:691-702.
27. Prater MR, Strahl ED, Zimmerman KL, Ward DL, Holladay SD. 2004. Reduced birth defects caused by maternal immune stimulation in methylnitrosourea-exposed mice: association with placental improvement. Birth Defects Res A 70:862-869.
28. Punareewattana K, Holladay SD. 2004. Immunostimulation by complete Freund's adjuvant, granulocyte macrophage colony-stimulating factor, or interferon-γ reduces severity of diabetic embryopathy in ICR mice. Birth Defects Research A 70:20-27.
29. Punareewattana K, Sharova LV, Li W, Ward DL, Holladay SD. 2003. Reduced birth defects caused by maternal immune stimulation may involve increased expression of growth promoting genes and cytokine GM-CSF in the spleen of diabetic ICR mice. Int Immunopharmacol 3:1639-1655.
30. Reece EA. 1999. Maternal fuels, diabetic embryopathy: pathomechanisms and prevention. Semin Reprod Endocrinol 17:183-194.
31. Sharova LV, Gogal RM Jr, Sharova AA, Crisman MV, Holladay SD. 2002, Immune stimulation in urethane-exposed pregnant mice increases expression of level of spleen leukocyte genes for TGFβ3, GM-CSF and other cytokines that may play a role in reduced chemical-induced birth defects. Int Immunopharmacol 2:1477-1489.
32. Sharova LV, Sharov AA, Sura P, Gogal RM Jr, Holladay SD. 2003. Maternal immune stimulation reduces both placental damage and down-regulated placental growth factor and cell cycle gene expression caused by urethane: are these events related to reduced birth teratogenesis? Int Immunopharmacol 3:945-955.
33. Sharova LV, Sura P, Smith BJ, Gogal RM Jr, Sharov AA, Ward DL, Holladay SD. 2000. Non-specific stimulation of the maternal immune system. II. Effects on fetal gene expression. Teratology 62:420-428.
34. Siman CM, Eriksson UJ. 1997. Vitamin C supplementation of the maternal diet reduces the rate of malformation in the offspring of diabetic rats. Diabetologia 40:1416-1424.
35. Siman CM, Gittenberger-De Groot AC, Wisse B, Eriksson UJ. 2000. Malformations in offspring of diabetic rats: morphometric analysis of neural crest-derived organs and effects of maternal vitamin E treatment. Teratology 61:355-367.
36. Sivan E, Reece EA, Wu YK, Homko CJ, Polansky M, Borenstein M. 1996. Dietary vitamin E prophylaxis and diabetic embryopathy: morphologic and biochemical analysis. Am J Obstet Gynecol 175:793-799.
37. Suzuki N, Svensson K, Eriksson UJ. 1996 High glucose concentration inhibits migration of rat cranial neural crest cells in vitro. Diabetologia 39:401-411.
38. Taylor LE, Bennett GD, Finnell RH. 1995. Altered gene expression in murine branchial arches following in utero exposure to retinoic acid. J Craniofac Genet Dev Biol 15:13-25.
39. Torchinsky A, Toder V, Savion S, Shepshelovich J, Orenstein H, Fein A. 1997. Immunostimulation increases the resistance of mouse embryos to the teratogenic effect of diabetes mellitus. Diabetologia 40:635-640.
40. Tudela C, Formoso MA, Martinez T, Perez R, Aparicio M, Maestro C, Del Rio A, Martinez E, Ferguson M, Martinez-Alvarez C. 2002. TGF-beta3 is required for the adhesion and intercalation of medial edge epithelial cells during palate fusion. Int J Dev Biol 46:333-336.
41. Wang R, Martinez-Frias ML, Graham JM Jr. 2002. Infants of diabetic mothers are at increased risk for the oculo-auriculo-vertebral sequence: A case-based and case-control approach. J Pediatr 141:611-617.
42. Williams JA, Mann FM, Brown NA. 1997. Gene expression domains as markers in developmental toxicity studies using mammalian embryo culture. Int J Dev Biol 41:359-364.
43. Wiznitzer A, Ayalon N, Hershkovitz R, Khamaisi M, Reece EA, Trischler H, Bashan N. 1999. Lipoic acid prevention of neural tube defects in offspring of rats with streptozocin-induced diabetes. Am J Obstet Gynecol 180:188-193.
44. Wlodarczyk BC, Craig JC, Bennett GD, Calvin JA, Finnell RH. 1996. Valproic acid-induced changes in gene expression during neurulation in a mouse model. Teratology 54:284-297.